Profile
- Teaching students of medicine, biomedicine, and biology as well as graduate students at the Graduate School for Cellular and Biomedical Sciences (GCB) at the University of Bern, in Switzerland and Leiden, NL
- Understanding the molecular mechanism associated with geni-urothelial cancer growth and progression
- Generation of AI drug prediction models
- Understand the molecular processes of obstructive and neurogenic bladder remodeling and bladder pain syndrome
- Investigation of pathophysiological processes that contribute to the lower urinary tract dysfunction at the molecular level using patients’ biopsies, in vitro cell-based and in vivo animal models
External Partners
Prof. Marianna Rapsomaniki, IBM Research Zurich; Prof. Alvaro Aytes Institut d’Investigació Biomèdica de Bellvitge, Program Against Cancer Therapeutic Resistance / Prostate Cancer Lab, Barcelona, Spain; Prof. Theodore Alexandrov EMBL-Heidelberg, Structural and Computational Biology / Spatial Metabolomics Lab, Heidelberg, Germany; Prof. Rosalyn Adam, Urological Diseases Research Center, Boston Children’s Hospital, Boston, USA; Prof. Todd Purves, Duke University, Durham USA; Swiss Institute for Bioinformatics, TKI Bern, ETH Zürich, Balgrist University Hospital, ZHAW and EPFL
Grants
- Swiss National Science Foundation (179265, 189149, 184933, 189369, 175773/1, 182966/1, 212298/1)
- Department of Defense Impact Award PC180280 (W81XWH-19-1-0432)
- Swiss Cancer League (KFS 4718-02-2019, KFS-4960-02-2020)
- Novartis Foundation for medical-biological Research
- Innosuisse (412.36.1 IP-LS, 104.320 IP-LS and 101.951 IP-LS)
- 3RCC OC-2019-003
- Initiator Grant (UBERN)
- Tandem/ Fondation ISREC
- Wilhelm Sander-Stiftung (2022.136.1)
- International Foundation for Research in Paraplegia
